risks of glp-1 drugs Medications: Is Ozempic the Best Option for You? GLP-1 nausea: How to handle
Description
The statistical analysis was carried out with Statistica 13.1 software (StatSoft Poland, Cracow, Poland)
For researchers whose metabolic profiles include kidney function concerns alongside weight management goals, dulaglutide fills a specific clinical niche that tirzepatide does not yet have formal data to support
It is also approved for cardiovascular risk reduction in adults with established cardiovascular disease and overweight or obesity
However, if you have gastroparesis, your stomach muscles move slowly or not at all, making it hard for your stomach to empty properly
In fact, they were approved for treatment of type 2 diabetes in 2005
